Stage IIIC Esophageal Cancer

7 clinical trials · Condition

Record	Firm	Date
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190)	Stanford University	2017-08-08
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810)	Eastern Cooperative Oncology Group	2015-03-06
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma (NCT02037048)	Case Comprehensive Cancer Center	2014-02-10
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery (NCT01612546)	City of Hope Medical Center	2012-11-01
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery (NCT01705340)	National Cancer Institute (NCI)	2012-09-01
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820)	Roswell Park Cancer Institute	2012-03-01
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer (NCT01212822)	Fox Chase Cancer Center	2011-04-27

Every clearance here is in the API, with alerts when new ones post.